Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 235 (8%)
Anticipated shortage: 19 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2017-10-11 2018-03-13 25304
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-27 2018-04-17 30805
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-12-20 2018-03-21 33867
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-ISMN 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-05-22 2018-08-09 50044
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55264
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2020-01-07 55267
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2018-08-01 55299

Showing 81 to 100 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823

Showing 41 to 60 of 356